← Leaderboards
Richard S Schottenfeld
Yale University
$12,878,104
Attributed
$15,668,557
Total exposure
9
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.2M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,668,557 · 9
By mechanism
R01$10,172,030 · 7
UG1$4,185,680 · 1
K24$1,310,847 · 1
Top collaborators
- Niranjan Subhash Karnik2 shared
- Antonio A. Morgan-Lopez2 shared
Most similar at Yale University
Same institution · by research overlap
- Thomas Richard Kosten$19,160,340
- Roman Shrestha$3,972,535
- Alison Oliveto Beaudoin$13,435,140
- Robert T Malison$17,226,399
- Joseph F. Cubells$7,878,696
Others in their field
Top investigators on “Buprenorphine”
- Sharon L. Walsh · University Of Kentucky$87,310,858
- Edward V Nunes · Columbia University Health Sciences$83,345,625
- T John Winhusen · University Of Cincinnati$34,249,969
- Walter Nmn Ling · University Of California Los Angeles$33,859,118
- Marco Pravetoni · Hennepin Healthcare Research Institute$33,709,846
- George E Woody · University Of Pennsylvania$33,075,022
Research focus
BuprenorphineDrug AbuseClinical TrialsHuman SubjectHuman Therapy EvaluationClinical ResearchCounselingTrainingCocaineBehavioralDrug Abuse ChemotherapyMalaysiaNaltrexonePharmaceutical PreparationsPlacebosMethadoneMaintenanceRandomizedMedicalResearch PersonnelCountryHeroinEffectivenessBehavior Therapy
Grant awards (42)
Great Lakes & Mid-Atlantic Node (GLMN) of the NIDA CTN (CTN-0144)$3,454,904
UG1 · FY2025 · DA
Great Lakes & Mid-Atlantic Node (GLMN) of the NIDA CTN$730,776
UG1 · FY2025 · DA
Drug Counseling and Abstinent-Contingent Take Home Buprenorphine in Malaysia$90,312
R01 · FY2013 · DA · contact PI
Pain and Opioid Dependence (POD)$349,189
R01 · FY2012 · DA · contact PI
Pain and Opioid Dependence (POD)$341,885
R01 · FY2011 · DA · contact PI
Drug Counseling and Abstinent-Contingent Take Home Buprenorphine in Malaysia$287,462
R01 · FY2011 · DA · contact PI
Pain and Opioid Dependence (POD)$365,339
R01 · FY2010 · DA · contact PI
Drug Counseling and Abstinent-Contingent Take Home Buprenorphine in Malaysia$346,979
R01 · FY2010 · DA · contact PI
Pain and Opioid Dependence (POD)$384,965
R01 · FY2009 · DA · contact PI
Drug Counseling and Abstinent-Contingent Take Home Buprenorphine in Malaysia$351,941
R01 · FY2009 · DA · contact PI
Improving Efficacy of Drug Abuse Treatment$159,162
K24 · FY2009 · DA · contact PI
Drug Counseling and Abstinent-Contingent Take Home Buprenorphine in Malaysia$100,956
R01 · FY2009 · DA · contact PI
Drug Counseling and Abstinent-Contingent Take Home Buprenorphine in Malaysia$427,973
R01 · FY2008 · DA · contact PI
Improving Efficacy of Drug Abuse Treatment$157,292
K24 · FY2008 · DA · contact PI
Drug Counseling and Abstinent-Contingent Take Home Buprenorphine in Malaysia$343,444
R01 · FY2007 · DA · contact PI
Improving Efficacy of Drug Abuse Treatment$155,346
K24 · FY2007 · DA · contact PI
Drug Counseling and Abstinent-Contingent Take Home Buprenorphine in Malaysia$85,410
R01 · FY2007 · DA · contact PI
Improving Efficacy of Drug Abuse Treatment$153,628
K24 · FY2006 · DA · contact PI
Improving Efficacy of Drug Abuse Treatment$151,663
K24 · FY2005 · DA
HIV Risk Reduction and Drug Abuse Treatment in Malaysia$379,640
R01 · FY2004 · DA
IMPROVING EFFICACY OF DRUG ABUSE TREATMENT$107,689
K24 · FY2004 · DA
COUNSELING CONDITONS FOR THRICE WEEKLY BUP IN A PCC$445,773
R01 · FY2003 · DA
DISULFIRAM FOR COCAINE ABUSE IN BUPRENORPHINE TREATMENT$442,553
R01 · FY2003 · DA
HIV Risk Reduction and Drug Abuse Treatment in Malaysia$388,803
R01 · FY2003 · DA
IMPROVING EFFICACY OF DRUG ABUSE TREATMENT$107,206
K24 · FY2003 · DA
COUNSELING CONDITONS FOR THRICE WEEKLY BUP IN A PCC$503,432
R01 · FY2002 · DA
DISULFIRAM FOR COCAINE ABUSE IN BUPRENORPHINE TREATMENT$423,776
R01 · FY2002 · DA
HIV Risk Reduction and Drug Abuse Treatment in Malaysia$370,642
R01 · FY2002 · DA
IMPROVING EFFICACY OF DRUG ABUSE TREATMENT$106,737
K24 · FY2002 · DA
HIV Risk Reduction and Drug Abuse Treatment in Malaysia$82,010
R01 · FY2002 · DA
COUNSELING CONDITONS FOR THRICE WEEKLY BUP IN A PCC$496,095
R01 · FY2001 · DA
DISULFIRAM FOR COCAINE ABUSE IN BUPRENORPHINE TREATMENT$427,383
R01 · FY2001 · DA
HIV Risk Reduction and Drug Abuse Treatment in Malaysia$363,266
R01 · FY2001 · DA
BRIEF BEHAVIORAL THERAPY TO ENHANCE TREATMENT ENGAGEMENT$309,081
R01 · FY2001 · DA
COMBINING BEHAVIORAL TREATMENTS WITH AGONIST MAINTENANCE$155,445
R01 · FY2001 · DA
IMPROVING EFFICACY OF DRUG ABUSE TREATMENT$106,283
K24 · FY2001 · DA
BEHAVIORAL TREATMENTS FOR COCAINE DEPENDENT WOMEN$539,377
R01 · FY2000 · DA
COUNSELING CONDITONS FOR THRICE WEEKLY BUP IN A PCC$472,294
R01 · FY2000 · DA
DISULFIRAM FOR COCAINE ABUSE IN BUPRENORPHINE TREATMENT$379,492
R01 · FY2000 · DA
BRIEF BEHAVIORAL THERAPY TO ENHANCE TREATMENT ENGAGEMENT$318,284
R01 · FY2000 · DA
COMBINING BEHAVIORAL TREATMENTS WITH AGONIST MAINTENANCE$198,829
R01 · FY2000 · DA
IMPROVING EFFICACY OF DRUG ABUSE TREATMENT$105,841
K24 · FY2000 · DA